PPARG and breast carcinoma: Moreover, substantial evidence demonstrates that in hormone-dependent breast cancer cells, ERα binding to PPRE elements represses PPARγ transactivation, implying that a functional crosstalk between the two receptors affects breast cancer progression [18].